KR930013103A - 종양 관련의 모노클로날 항체 88bv59 - Google Patents

종양 관련의 모노클로날 항체 88bv59 Download PDF

Info

Publication number
KR930013103A
KR930013103A KR1019920023925A KR920023925A KR930013103A KR 930013103 A KR930013103 A KR 930013103A KR 1019920023925 A KR1019920023925 A KR 1019920023925A KR 920023925 A KR920023925 A KR 920023925A KR 930013103 A KR930013103 A KR 930013103A
Authority
KR
South Korea
Prior art keywords
acid sequence
amino acid
identified
monoclonal antibody
tumor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1019920023925A
Other languages
English (en)
Korean (ko)
Inventor
빅토 하스펠 마틴
제이 코브린 베리
제위 크리크톤 버지니아
Original Assignee
에프. 지. 엠 헤르만스, 에이. 지. 제이.베어미렌
악조 엔. 브이.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 에프. 지. 엠 헤르만스, 에이. 지. 제이.베어미렌, 악조 엔. 브이. filed Critical 에프. 지. 엠 헤르만스, 에이. 지. 제이.베어미렌
Publication of KR930013103A publication Critical patent/KR930013103A/ko
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cell Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
KR1019920023925A 1991-12-13 1992-12-11 종양 관련의 모노클로날 항체 88bv59 Ceased KR930013103A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US80730091A 1991-12-13 1991-12-13
US07/807,300 1991-12-13

Publications (1)

Publication Number Publication Date
KR930013103A true KR930013103A (ko) 1993-07-21

Family

ID=25196057

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019920023925A Ceased KR930013103A (ko) 1991-12-13 1992-12-11 종양 관련의 모노클로날 항체 88bv59

Country Status (12)

Country Link
EP (1) EP0546634A3 (enExample)
JP (1) JP3539985B2 (enExample)
KR (1) KR930013103A (enExample)
AU (1) AU651261B2 (enExample)
CA (1) CA2083542A1 (enExample)
FI (1) FI925638L (enExample)
HU (1) HU218081B (enExample)
IL (1) IL103758A (enExample)
NO (1) NO924803L (enExample)
NZ (1) NZ245443A (enExample)
TW (1) TW271450B (enExample)
ZA (1) ZA928880B (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5198704B2 (ja) 2000-03-03 2013-05-15 メディミューン リミティド エオタキシンに対するヒト抗体及びそれらの使用
US6946546B2 (en) 2000-03-06 2005-09-20 Cambridge Antibody Technology Limited Human antibodies against eotaxin

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4322879A (en) * 1978-01-11 1979-07-19 Massachusetts General Hospital, The Producing antibodies
US4172124A (en) 1978-04-28 1979-10-23 The Wistar Institute Method of producing tumor antibodies
US4997762A (en) 1984-01-31 1991-03-05 Akzo N.V. Tumor associated monocoloal antibodies derived from human B-cell line
US4828991A (en) 1984-01-31 1989-05-09 Akzo N.V. Tumor specific monoclonal antibodies
NZ210867A (en) * 1984-01-31 1989-01-06 Litton Bionetics Inc Tumour-specific monoclonal antibodies, production thereof and use
WO1989000050A1 (en) * 1987-07-02 1989-01-12 Akzo N.V. Antigen recognized by mca 16-88

Also Published As

Publication number Publication date
NO924803D0 (no) 1992-12-11
FI925638A7 (fi) 1993-06-14
AU651261B2 (en) 1994-07-14
FI925638A0 (fi) 1992-12-11
HUT65480A (en) 1994-06-28
FI925638L (fi) 1993-06-14
IL103758A0 (en) 1993-04-04
HU218081B (hu) 2000-05-28
HU9203932D0 (en) 1993-04-28
NZ245443A (en) 1995-12-21
JPH05317042A (ja) 1993-12-03
JP3539985B2 (ja) 2004-07-07
CA2083542A1 (en) 1993-06-14
ZA928880B (en) 1993-08-12
AU3008892A (en) 1993-06-17
EP0546634A3 (en) 1994-09-21
IL103758A (en) 1998-07-15
TW271450B (enExample) 1996-03-01
NO924803L (no) 1993-06-14
EP0546634A2 (en) 1993-06-16

Similar Documents

Publication Publication Date Title
Mirick et al. A review of human anti-globulin antibody (HAGA, HAMA, HACA, HAHA) responses to monoclonal antibodies. Not four letter words
ATE350478T1 (de) Monoklonaler antikoerper gegen cea, konjugate die dieses antikoerper enthalten und deren therapeutische verwendung in einem adept-system
NZ614727A (en) Human antibodies that bind human tnfa
PT699237E (pt) Fvs de cadeia anti-egfr e anticorpos anti-egfr
NZ568403A (en) CD20-specific antibodies and methods of employing same
CA2082160A1 (en) Humanised and chimeric monoclonal antibodies
RU96115107A (ru) "очеловеченные" антитела и их использование
EA200301098A1 (ru) Ассоциированные с ганглиозидами рекомбинантные антитела и их применение в диагностике и лечении опухолей
CA2250080A1 (en) Humanization of an anti-carcinoembryonic antigen anti-idiotype antibody and use as a tumor vaccine and for targeting applications
KR920702425A (ko) Cdr 이식된 항-cea 항체 및 그의 제조
DK1098909T3 (da) Hybride menneske/gnaver igg-antistoffer mod cd3 og fremgangsmåder til fremstilling deraf
DK164510C (da) Humant hybridom, humant monoklonalt antistof opnaaet derfra, anvendelse af et saadant antistof og fremgangsmaade til fremstilling af et saadant antistof
RU93055358A (ru) V-области н-и l-цепей антител, химерные антитела, сдr-последовательности, l-и н-цепи антител, днк, вектор, клетка, способы получения антител
ATE301471T1 (de) Verwendung von antikörpen gegen cd45ro leukozytenantigen zur immunmodulation
ATE129902T1 (de) Monoklonale antikörper gegen den bereich der leichten kette von menschlichem faktor xii sowie methoden zu deren herstellung und verwendung.
CA2012993A1 (en) Monoclonal antibodies (mabs) against tumor-associated antigens, the preparation and use thereof
ATE115412T1 (de) Anti-idiotyp-antikörper gegen antimenschliche hochmolekulare, an melanomen assoziierte antigene.
ATE123066T1 (de) Monoklonale antikörper und herstellung eines impfstoffes gegen menschliche krebsantigene durch immunisierung mit menschlichem und tierischem mucin und mit synthetischen gluciden- trägerkonjugaten.
KR930013103A (ko) 종양 관련의 모노클로날 항체 88bv59
ATE77243T1 (de) E87ag-antigen des pseudomonas aeruginosa, monoklonale antikoerper dagegen und hybridom.
DK0537168T3 (da) Antigenet CTAA 28A32, som genkendes af MCA 28A32
JPWO2021171002A5 (enExample)
Hashizume et al. Clinical applications of human monoclonal antibodies
RU2021104205A (ru) Антитела против mica/b, блокирующие шеддинг mica/b, и способы их применения
Yermakov et al. Monoclonal IgG antibodies against Shigella flexneri VI LPS.

Legal Events

Date Code Title Description
PA0109 Patent application

Patent event code: PA01091R01D

Comment text: Patent Application

Patent event date: 19921211

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 19971114

Comment text: Request for Examination of Application

Patent event code: PA02011R01I

Patent event date: 19921211

Comment text: Patent Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 19990929

Patent event code: PE09021S01D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20000222

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 19990929

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I